Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipase family member J (LIPJ) is a protein-coding enzyme predicted to catalyze hydrolysis of ester bonds in lipid molecules. It is part of the broader lipase family, which are hydrolases involved in cellular lipid catabolism and processing. LIPJ is active at intracellular membrane-bounded organelles and likely participates in metabolic pathways, such as keratinization and nervous system development, but its specific physiological function is not fully elucidated. Disease associations have been reported with rare syndromes, such as Cerebrooculofacioskeletal Syndrome 4 and Wolman Disease. No direct drug interventions or established biomarker uses are documented for LIPJ at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipase family member J (LIPJ).